Fig. 1
Patients flow chart. HCC hepatocellular carcinoma, TKI tyrosine kinase inhibitor, PD-1 programmed cell death protein-1, HBV hepatitis B virus, HBsAg hepatitis B surface antigen.
Fig. 1 | Scientific Reports
Patients flow chart. HCC hepatocellular carcinoma, TKI tyrosine kinase inhibitor, PD-1 programmed cell death protein-1, HBV hepatitis B virus, HBsAg hepatitis B surface antigen.
